Literature DB >> 12927779

Bioinformatics of granzymes: sequence comparison and structural studies on granzyme family by homology modeling.

Rabia Sattar1, S Abid Ali, Atiya Abbasi.   

Abstract

Cytotoxic lymphocytes (CTLs), the key players of cell mediated immunity, induce apoptosis by engaging death receptors or through exocytosis of cytolytic granules containing granzyme (proteases) and pore-forming protein (perforin). The crystal structure of granzyme B from human (B(h)) and rat (B(r)), as well as that of pro-granzyme K (K(h)) has been reported recently. In the present communication, we describe the homology modeling of granzyme family (in particular Gzm A(h), M(h), B(m), and C(m) from human and mouse) based on the crystal structural coordinates of trypsin, granzyme K (K(h)), and granzyme B (B(h)). These models have been used for establishing phylogenetic relationship as well as identifying characteristic features for designing specific inhibitors. The paper also highlights key residues at the S1, S2, and S2(') binding subsites in all granzyme, which may be involved in the structure-function relationship of this enzyme family. The predicted 3D homology models show a conserved two similar domain structure, i.e., an N-terminal domain and a C-terminal domain comprising predominantly of beta-sheet structure with a little alpha-helical content. Micro-heterogeneities have been observed in the vicinity of the active site in all granzymes as compared to granzyme B(h). For example, in granzyme M(h), valine is present at the S1 subsite instead of arginine. Similarly differences at S2 (Leu-->Phe), S3 (Ser-->Gly), and S4 (Arg-->Asn) subsites are quite apparent and appear to hold the potential for selective designing of inhibitors for possible therapeutic applications. Furthermore, analysis of the electrostatic surface potential on the shape of granzyme-inhibitor binding groove reveals clear differences at the reactive site. Additionally the different posttranslational modification sites such as phosphorylation (e.g., in granzyme M Thr101, Ser109), myristoylation (Gly22, 117, and 131), and glycosylation (Ser160) have been identified, as very little is known about the functional significance of these modifications in the granzyme family. Thus, glycosylation at Ser160 in granzyme M may influence the net charge of the enzyme, resulting in altered substrate binding as compared to granzyme B. Also this modification may influence the rate of complexation and binding affinity with proteoglycans. These studies are expected to contribute towards the basic understanding of functional associations of the granzymes with other molecules and their possible role in apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927779     DOI: 10.1016/s0006-291x(03)01458-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

2.  Granzyme B enters the mitochondria in a Sam50-, Tim22- and mtHsp70-dependent manner to induce apoptosis.

Authors:  Valentina Chiusolo; Guillaume Jacquemin; Esen Yonca Bassoy; Laurent Vinet; Lavinia Liguori; Michael Walch; Vera Kozjak-Pavlovic; Denis Martinvalet
Journal:  Cell Death Differ       Date:  2017-03-24       Impact factor: 15.828

3.  Molecular characterization and expression of a granzyme of an ectothermic vertebrate with chymase-like activity expressed in the cytotoxic cells of Nile tilapia (Oreochromis niloticus).

Authors:  Kesavannair Praveen; John H Leary; Donald L Evans; Liliana Jaso-Friedmann
Journal:  Immunogenetics       Date:  2006-02-09       Impact factor: 2.846

4.  Granzyme B Induces IRF-3 Phosphorylation through a Perforin-Independent Proteolysis-Dependent Signaling Cascade without Inducing Cell Death.

Authors:  Eric J Gapud; Maria Isabel Trejo-Zambrano; Eduardo Gomez-Banuelos; Eleni Tiniakou; Brendan Antiochos; David J Granville; Felipe Andrade; Livia Casciola-Rosen; Antony Rosen
Journal:  J Immunol       Date:  2020-12-07       Impact factor: 5.422

5.  Predictions of Cleavability of Calpain Proteolysis by Quantitative Structure-Activity Relationship Analysis Using Newly Determined Cleavage Sites and Catalytic Efficiencies of an Oligopeptide Array.

Authors:  Fumiko Shinkai-Ouchi; Suguru Koyama; Yasuko Ono; Shoji Hata; Koichi Ojima; Mayumi Shindo; David duVerle; Mika Ueno; Fujiko Kitamura; Naoko Doi; Ichigaku Takigawa; Hiroshi Mamitsuka; Hiroyuki Sorimachi
Journal:  Mol Cell Proteomics       Date:  2016-01-21       Impact factor: 5.911

6.  Identification and annotation of bovine granzyme genes reveals a novel granzyme encoded within the trypsin-like locus.

Authors:  Jie Yang; Christina Vrettou; Tim Connelley; W Ivan Morrison
Journal:  Immunogenetics       Date:  2018-06-08       Impact factor: 2.846

Review 7.  Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.

Authors:  Zachary L Z Hay; Jill E Slansky
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 6.208

8.  Improved Purification of Human Granzyme A/B and Granulysin Using a Mammalian Expression System.

Authors:  Valerio Rasi; Owais Abdul Hameed; Patricia Matthey; Sibes Bera; Duane P Grandgenett; Stefan Salentinig; Michael Walch; Daniel F Hoft
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

9.  Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B).

Authors:  Tracey M Ferrara; Ying Jin; Katherine Gowan; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2013-01-15       Impact factor: 8.551

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.